Medtech Hologic公司报告的收入比预期的2 2021年Q2收入好,EPS收入为1.06美元。 Medtech firm Hologic reported better-than-expected Q2 2021 earnings, with EPS of $1.06.
医疗科技公司Hologic报告了 2021 年第二季度的收益比预期好,每股收益为 1.06 美元,而分析师估计为 1.02 美元. Medtech firm Hologic reported better-than-expected Q2 2021 earnings, with EPS of $1.06 compared to analyst estimates of $1.02. 公司的季度收入为10亿美元,同比增长2.7%. The firm's revenue for the quarter was $1.01 billion, a 2.7% increase year-over-year. Hologic的净利润率为17.59%,股本回报率为19.65%。 Hologic's net margin was 17.59%, and the return on equity was 19.65%. 该公司的目前比率为3.97,债务与股本比率为0.52。 The company has a current ratio of 3.97 and a debt-to-equity ratio of 0.52. Hologic CEO Stephen P. Macmillan于7月17日出售了该公司的3 672股股票,总价值为294 237.36美元,但仍拥有该公司的1 157 562股股票。 Hologic CEO Stephen P. Macmillan sold 3,672 shares of the company's stock for a total value of $294,237.36 on July 17th but still owns 1,157,562 shares in the company. 为妇女健康开发、制造和供应诊断产品、医疗成像系统和外科产品。 Hologic develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health.